Posted in MIMS/UK 01 October 2010 The marketing authorisation for Cervarix has been updated to show that it offers broader protection against human papillomavirus (HPV) than first thought. Cervarix was originally indicated to protect against only the two HPV types it contains—16 and 18—which are collectively responsible for around 70 per cent of all cervical […]